IMVT

Immunovant Inc · NASDAQ

Sector Health Technology
Industry Biotechnology
Website immunovant.com
Employees(FY) 164
ISIN US45258J1025

Performance

-11.11%

-12.9%

-31.08%

-27.8%

-16.03%

YTD

-42.87%

Profile

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Advanced Technical Analysis

Technical Analysis of IMVT 2025-02-03

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 3, Oscillators Score at 36, and a Technical Score of 10, indicating overall weakness in the market. The low scores suggest a lack of bullish momentum and potential downward pressure on the stock.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of IMVT

Stock Rank

Recent News & Updates

2024-09-05 11:31
Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report?(Zacks)
2024-09-05 06:30
Immunovant to Host Graves’ Disease Program Update on September 9, 2024(GlobeNewswire)
2024-09-04 18:30
Immunovant to Host Graves' Disease Program Update on September 9, 2024(Globenewswire)
2024-09-02 06:48
Are Investors Undervaluing Immunovant, Inc. (NASDAQ:IMVT) By 46%?(Simply Wall St.)
2024-08-23 16:13
Immunovant Insider Sold Shares Worth $480,052, According to a Recent SEC Filing(MT Newswires)
2024-08-13 09:59
UBS Trims Price Target on Immunovant to $41 From $42, Maintains Buy Rating(MT Newswires)
2024-08-09 00:20
Q1 2025 Roivant Sciences Ltd Earnings Call(Thomson Reuters StreetEvents)
2024-08-06 16:05
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024(GlobeNewswire)
2024-07-23 09:37
We Think Immunovant (NASDAQ:IMVT) Can Afford To Drive Business Growth(Simply Wall St.)
2024-07-19 17:41
Immunovant Insider Sold Shares Worth $257,888, According to a Recent SEC Filing(MT Newswires)
2024-07-11 06:37
Daily – Vickers Top Buyers & Sellers for 07/11/2024(Argus Research)
2024-07-08 11:06
Dianthus (DNTH) Gains 18% in the Past Month: Here's Why(Zacks)
2024-06-28 11:30
Immunovant (IMVT) Down 1.6% Since Last Earnings Report: Can It Rebound?(Zacks)
2024-06-27 23:30
Immunovant (IMVT) Down 1.6% Since Last Earnings Report: Can It Rebound?(Zacks)
2024-06-03 08:29
Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating(MT Newswires)
2024-05-31 02:26
Q4 2024 Roivant Sciences Ltd Earnings Call(Thomson Reuters StreetEvents)
2024-05-30 20:04
Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-05-30 16:02
After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay(Investor's Business Daily)
2024-05-30 11:29
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus(Zacks)
2024-05-30 07:22
Immunovant changes up plans for closely watched autoimmune drugs(BioPharma Dive)
2024-05-29 23:29
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus(Zacks)
2024-05-29 17:53
Immunovant shunts next-gen FcRn drug ahead of batoclimab in race to rival Vyvgart(Fiercebiotech)
2024-05-29 16:45
Immunovant Q4 Loss Widens -- Shares Fall After-Hours(MT Newswires)
2024-05-29 16:06
Biohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump(Investor's Business Daily)
2024-05-29 16:01
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024(GlobeNewswire)
2024-05-29 09:53
IMVT Stock Earnings: Immunovant Misses EPS for Q4 2024(Investorplace)
2024-05-29 04:01
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024(Globenewswire)
2024-05-28 21:12
Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump(Yahoo Finance)
2024-05-27 06:28
Institutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV)(Insidermonkey)
2024-05-24 16:23
Immunovant Insider Sold Shares Worth $479,233, According to a Recent SEC Filing(MT Newswires)

Page 2 of 7

previous next

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.